Pune: Pune-based vaccine manufacturer Serum Institute of India plans to start clinical trials of the Novavax shot for children against Covid-19 in July.
News agency ANI quoted its sources saying, "Serum Institute of India plans to start clinical trials of the Novavax shot for children in July."
In addition to this, SII also hopes to introduce Covavax in the country by September which is a version of US firm Novavax's COVID19 vaccine candidate.
Developed by the Maryland-based biotechnology company Novavax, vaccine candidate called NVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
NVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19. It is being evaluated in two pivotal Phase 3 trials.
Earlier this week, the Biotech firm Novavax said that its Covid-19 vaccine is highly effective against COVID-19 in a large study and also protects against variants. The vaccine maker announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100 per cent protection against moderate and severe disease, 90.4 per cent efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial.
ALSO READ | Single Dose Of Covishield 61% Effective; Will Revisit Vaccine Interval With Fresh Data: NTAGI Chief
Meanwhile, the All India Institute of Medical Sciences (AIIMS) in Delhi started clinical trials Of Covaxin vaccine on Children aged 6-12.
According to reports, the recruitment for the clinical trial of the country's first indigenously-developed COVID-19 vaccine among children began from Tuesday (June 15). This will be followed by the clinical trial of children in the age-group of 2-6 years.
As per latest inputs, a doctor couple from New Delhi got their two children vaccinated. The two are said to 9-year-old twins. The doctor couple got their children vaccinated in Kanpur.